Related Experiment Videos
AI Risk Prediction Tools for Autologous Breast Reconstruction
Jonlin Chen1, Ariel Gabay1, Abbas M Hassan2
1Plastic and Reconstructive Surgery Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Journal of Surgical Oncology
|July 22, 2026
Summary
This study developed statistical and machine learning models to predict 90-day complications after autologous breast reconstruction, identifying key risk factors like BMI and chemotherapy. These models aim to personalize patient treatment and improve outcomes.
Area of Science:
- Plastic Surgery
- Surgical Oncology
- Biostatistics
Background:
- Autologous breast reconstruction offers a durable, natural option post-mastectomy.
- Complications such as flap loss, infection, and delayed healing remain significant risks.
- Predictive models are needed to identify patients at higher risk for adverse outcomes.
Purpose of the Study:
- To develop and compare traditional statistical and machine learning (ML) models for predicting 90-day postoperative complications following autologous breast reconstruction.
- To identify key predictors of complications including infection, hematoma, seroma, delayed wound healing, and flap compromise.
Main Methods:
- Retrospective analysis of 2,128 patients undergoing abdominal-based autologous breast reconstruction.
- Development of multivariable logistic regression and supervised ML models.
- Evaluation of model performance using Area Under the Curve (AUC) and identification of key predictors via SHAP analysis.
Main Results:
- A 22.3% overall complication rate within 90 days, with infection (10%) and hematoma (6%) being most common.
- ML models demonstrated superior predictive performance (AUCs 0.64-0.73) compared to logistic regression (AUCs 0.60-0.66).
- Higher BMI and neoadjuvant chemotherapy were associated with increased complication risks; age, BMI, and pre-reconstruction radiation were key ML predictors.
Conclusions:
- Both statistical and ML models can predict complications after autologous breast reconstruction.
- ML models show promise for enhancing individualized risk assessment and potentially personalizing treatment strategies.
- Further research is necessary to improve model accuracy and clinical applicability for patient care.